Your browser doesn't support javascript.
loading
Genomic and TCR profiling data reveal the distinct molecular traits in epithelial ovarian cancer histotypes.
Zhu, Shan; Zhang, Chunliu; Cao, Dongyan; Bai, Jing; Yu, Shuangni; Chen, Jie; Wang, Jing; Ren, Tong; Yang, Jiaxin; Yu, Mei; Xiao, Xiao; Gong, Yuhua; Guan, Yanfang; Li, Peiling; Yue, Ying; Yin, Rutie; Wang, Yongjun; An, Ruifang; Lou, Ge; Yuan, Jianlin; Zhang, Guonan; Xia, Xuefeng; Yang, Ling; Xiang, Yang.
Afiliación
  • Zhu S; Department of Obstetrics and Gynecology, National Clinical Research Centre for Obstetric and Gynecologic Diseases, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Zhang C; Geneplus institute, Beijing, China.
  • Cao D; Department of Obstetrics and Gynecology, National Clinical Research Centre for Obstetric and Gynecologic Diseases, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Bai J; Geneplus institute, Beijing, China.
  • Yu S; Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
  • Chen J; Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
  • Wang J; Department of Gynecology Oncology, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
  • Ren T; Department of Obstetrics and Gynecology, National Clinical Research Centre for Obstetric and Gynecologic Diseases, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Yang J; Department of Obstetrics and Gynecology, National Clinical Research Centre for Obstetric and Gynecologic Diseases, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Yu M; Department of Obstetrics and Gynecology, National Clinical Research Centre for Obstetric and Gynecologic Diseases, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Xiao X; Geneplus-Shenzhen, Shenzhen, China.
  • Gong Y; Geneplus institute, Beijing, China.
  • Guan Y; Geneplus institute, Beijing, China.
  • Li P; Department of Obstetrics and Gynecolgoy, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Yue Y; Department of Gynecological Oncology, First Hospital of Jilin University, Changchun, China.
  • Yin R; Department of Obstetrics and Gynecology, West China Second Hospital of Sichuan University, Chengdu, China.
  • Wang Y; Department of Obstetrics and Gynecology, Peking University International Hospital, Beijing, China.
  • An R; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Xi'an Jiaotong University, Shaanxi, China.
  • Lou G; Department of Gynecology Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
  • Yuan J; Department of Gynecology, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, China.
  • Zhang G; Department of Gynecologic Oncology, Sichuan Cancer Hospital, Chengdu, China.
  • Xia X; Geneplus institute, Beijing, China.
  • Yang L; Geneplus institute, Beijing, China. yangl@geneplus.org.cn.
  • Xiang Y; Department of Obstetrics and Gynecology, National Clinical Research Centre for Obstetric and Gynecologic Diseases, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. xi
Oncogene ; 41(22): 3093-3103, 2022 05.
Article en En | MEDLINE | ID: mdl-35468938

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncogene Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncogene Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2022 Tipo del documento: Article